A Personalized Vaccine for the Immune Prevention of Multiple Myeloma
MD Anderson Study Status
Lenalidomide, Vaccine Therapy
This early phase I trial studies the side effects of personalized vaccine in treating patients with smoldering multiple myeloma. Vaccines made from a person's blood and bone marrow may help the body build an effective immune response to kill cancer cells.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Smoldering Plasma Cell Myeloma
For general questions about clinical trials:
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.